Investor Relations

Events

Paradigm Capital Biosynthesis Conference
Monday, April 15, 2019

Thomas D. Reed, PhD, Founder and Chief Science Officer of Intrexon, presented at the Paradigm Capital Biosynthesis Conference on April 15, 2019 in Toronto. Dr. Reed highlighted Intrexon’s proprietary yeast strain engineering, which enables a transformative process for robust production of cannabinoids with consistent yield and purity and is designed to facilitate production of multiple target cannabinoids. The presentation was not webcast.